Search Results - "Gerke, Julia S"
-
1
Robust diagnosis of Ewing sarcoma by immunohistochemical detection of super-enhancer-driven EWSR1-ETS targets
Published in Oncotarget (05-01-2018)“…Ewing sarcoma is an undifferentiated small-round-cell sarcoma. Although molecular detection of pathognomonic fusions such as enables definitive diagnosis,…”
Get full text
Journal Article -
2
Functional genomics identifies AMPD2 as a new prognostic marker for undifferentiated pleomorphic sarcoma
Published in International journal of cancer (15-02-2019)“…Soft‐tissue sarcomas are rare, heterogeneous, and often aggressive mesenchymal cancers. Many of them are associated with poor outcome, partially because…”
Get full text
Journal Article -
3
Focal adhesion kinase confers pro‐migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
Published in Molecular oncology (01-02-2020)“…Oncogenesis of Ewing sarcoma (EwS), the second most common malignant bone tumor of childhood and adolescence, is dependent on the expression of chimeric…”
Get full text
Journal Article -
4
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Published in Modern pathology (01-06-2018)Get full text
Journal Article -
5
Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes
Published in Nature communications (11-09-2019)“…Pediatric malignancies including Ewing sarcoma (EwS) feature a paucity of somatic alterations except for pathognomonic driver-mutations that cannot explain…”
Get full text
Journal Article -
6
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
Published in Cell reports (Cambridge) (06-12-2022)“…Ewing sarcoma (EwS) is characterized by EWSR1-ETS fusion transcription factors converting polymorphic GGAA microsatellites (mSats) into potent neo-enhancers…”
Get full text
Journal Article -
7
Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
Published in Nature communications (15-05-2020)“…Ewing sarcoma (EwS) is an aggressive childhood cancer likely originating from mesenchymal stem cells or osteo-chondrogenic progenitors. It is characterized by…”
Get full text
Journal Article -
8
Integrative clinical transcriptome analysis reveals TMPRSS2‐ERG dependency of prognostic biomarkers in prostate adenocarcinoma
Published in International journal of cancer (01-04-2020)“…In prostate adenocarcinoma (PCa), distinction between indolent and aggressive disease is challenging. Around 50% of PCa are characterized by TMPRSS2‐ERG…”
Get full text
Journal Article -
9
Are EWSR1-NFATc2-positive sarcomas really Ewing sarcomas?
Published in Modern pathology (01-06-2018)Get full text
Journal Article -
10
Publisher Correction: Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma
Published in Nature communications (23-11-2020)“…A Correction to this paper has been published: https://doi.org/10.1038/s41467-020-20017-2…”
Get full text
Journal Article -
11
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma
Published in Cancers (10-03-2020)“…Ewing sarcoma (EwS) is an aggressive cancer displaying an undifferentiated small-round-cell histomorphology that can be easily confused with a broad spectrum…”
Get full text
Journal Article -
12
Targeting the CALCB/RAMP1 axis inhibits growth of Ewing sarcoma
Published in Cell death & disease (11-02-2019)“…Ewing sarcoma (EwS) is an aggressive cancer characterized by chromosomal translocations generating fusions of the EWSR1 gene with ETS transcription factors (in…”
Get full text
Journal Article -
13
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients
Published in EBioMedicine (01-09-2019)“…Up to 30–40% of Ewing sarcoma (EwS) patients with non-metastatic disease develop local or metastatic relapse within a time span of 2–10 years. This is in part…”
Get full text
Journal Article -
14
Systematic identification of cancer-specific MHC-binding peptides with RAVEN
Published in Oncoimmunology (02-09-2018)“…Immunotherapy can revolutionize anti-cancer therapy if specific targets are available. Immunogenic peptides encoded by cancer-specific genes (CSGs) may enable…”
Get full text
Journal Article -
15
Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens
Published in Oncotarget (30-08-2016)“…Autologous as well as allogeneic CD8+ T cells transduced with tumor antigen specific T cell receptors (TCR) may cause significant tumor lysis upon adoptive…”
Get full text
Journal Article -
16
Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patientsResearch in context
Published in EBioMedicine (01-09-2019)“…Background: Up to 30–40% of Ewing sarcoma (EwS) patients with non-metastatic disease develop local or metastatic relapse within a time span of 2–10 years. This…”
Get full text
Journal Article